Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Dul M, Alali M, Ameri M, Burke MD, Craig CM, Creelman BP, Dick L, Donnelly RF, Eakins MN, Frivold C, Forster AH, Gilbert PA, Henke S, Henry S, Hunt D, Lewis H, Maibach HI, Mistilis JJ, Park JH, Prausnitz MR, Robinson DK, Hernandez CAR, Ross C, Shin J, Speaker TJ, Taylor KM, Zehrung D, Birchall JC, Jarrahian C, Coulman SA. Dul M, et al. J Control Release. 2023 Sep;361:236-245. doi: 10.1016/j.jconrel.2023.07.001. Epub 2023 Aug 8. J Control Release. 2023. PMID: 37437849 Free article.
Hydrodynamic gene delivery in human skin using a hollow microneedle device.
Dul M, Stefanidou M, Porta P, Serve J, O'Mahony C, Malissen B, Henri S, Levin Y, Kochba E, Wong FS, Dayan C, Coulman SA, Birchall JC. Dul M, et al. J Control Release. 2017 Nov 10;265:120-131. doi: 10.1016/j.jconrel.2017.02.028. Epub 2017 Feb 28. J Control Release. 2017. PMID: 28254630
Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
Tatovic D, McAteer MA, Barry J, Barrientos A, Rodríguez Terradillos K, Perera I, Kochba E, Levin Y, Dul M, Coulman SA, Birchall JC, von Ruhland C, Howell A, Stenson R, Alhadj Ali M, Luzio SD, Dunseath G, Cheung WY, Holland G, May K, Ingram JR, Chowdhury MMU, Wong FS, Casas R, Dayan C, Ludvigsson J. Tatovic D, et al. Among authors: dul m. Immunother Adv. 2022 Jan 27;2(1):ltac002. doi: 10.1093/immadv/ltac002. eCollection 2022. Immunother Adv. 2022. PMID: 35919496 Free PMC article.
ISCEV and IPS guideline for the full-field stimulus test (FST).
Jolly JK, Grigg JR, McKendrick AM, Fujinami K, Cideciyan AV, Thompson DA, Matsumoto C, Asaoka R, Johnson C, Dul MW, Artes PH, Robson AG. Jolly JK, et al. Among authors: dul mw. Doc Ophthalmol. 2024 Feb;148(1):3-14. doi: 10.1007/s10633-023-09962-7. Epub 2024 Jan 18. Doc Ophthalmol. 2024. PMID: 38238632 Free PMC article.
Contrast Sensitivity of ON and OFF Human Retinal Pathways in Myopia.
Poudel S, Jin J, Rahimi-Nasrabadi H, Dellostritto S, Dul MW, Viswanathan S, Alonso JM. Poudel S, et al. Among authors: dul mw. J Neurosci. 2024 Jan 17;44(3):e1487232023. doi: 10.1523/JNEUROSCI.1487-23.2023. J Neurosci. 2024. PMID: 38050109 Free PMC article.
Self-limiting resolution of netarsudil induced bullous epitheliopathy.
Dellostritto S, Winter K, Gould Blackmore J, Pereira S, Dul MW. Dellostritto S, et al. Among authors: dul mw. Clin Exp Optom. 2022 Oct 24:1-3. doi: 10.1080/08164622.2022.2133992. Online ahead of print. Clin Exp Optom. 2022. PMID: 36281532 No abstract available.
74 results